Gyre Therapeutics, Inc. (GYRE)
7.865
-0.60
(-7.03%)
USD |
NASDAQ |
Dec 11, 16:00
7.865
0.00 (0.00%)
After-Hours: 17:20
Gyre Therapeutics Profit Margin (Quarterly): 19.42% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 27.14% |
| Savara, Inc. | -- |
| Exelixis, Inc. | 32.38% |
| Vanda Pharmaceuticals, Inc. | -40.15% |
| Aldeyra Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 10.40% |
| Return on Assets | 8.53% |
| Return on Invested Capital | 10.26% |
| Gross Profit Margin (Quarterly) | 94.67% |
| Operating Margin (Quarterly) | 22.66% |
| Return on Net Operating Assets | 19.40% |